Should also note that sales growth has been quite impressive for the last few reporting periods, so the multiples used above could be conservative if that continues.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025